Locations:
Search IconSearch

Tag: obstructive sleep apnea (OSA)

Inspire device
June 12, 2023/Neurosciences

Upper Airway Neurostimulation Device for the Treatment of Obstructive Sleep Apnea

For patients with moderate to severe OSA who are intolerant of traditional CPAP therapy, HNS may provide a welcome improvement to QoL

HNS device implantation

Considering Hypoglossal Nerve Stimulation as an Alternative for Treating Obstructive Sleep Apnea

New findings suggest that the therapy is associated with sustained improvements regarding insomnia, depression and quality of life

21-NEU-2437863 hypoglossal-nerve-stimulation-OSA_650x450
March 2, 2022/Neurosciences/Podcast

Neurostimulation for Treatment of Obstructive Sleep Apnea (Podcast)

An in-depth look at this alternative for patients who cannot tolerate PAP therapy

Kominsky, MD, in surgery

FDA Approves New Surgical Approach for Neurostimulation Device to Treat OSA

A reduction in the number of incisions for implantation simplifies the procedure and improves patient experience

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Hypoglossal stimulation
August 12, 2020/Neurosciences/Research

Is Upper Airway Stimulation for OSA Being Denied to Many Patients Who Can Benefit Most?

Study finds high coverage denial for women, patients with prior oral appliance use

20-NEU-038-sleep-apnea_650x450

Beyond Heart Health: Consequences of Obstructive Sleep Apnea

Exploring links to depression, metabolic disease, cognitive impairment and more

19-NEU-3980-sleep-apnea_650x450
October 7, 2019/Neurosciences/Research

Obstructive Sleep Apnea: How Do the Leading Therapies Stack Up in Effects on Sleepiness and Blood Pressure?

Retrospective clinic-based study provides intriguing initial comparisons

19-ENT-4228_CQD_Hero-650×450

Improving OSA Outcomes in a New Era of Sleep Surgery

Two studies reveal new insights about upper airway stimulation therapy

19-NEU-321-excessive-sleepiness-650×450

Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial

New drug for adults with OSA or narcolepsy expected to launch soon

Hypoglossal nerve stimulation
January 23, 2019/Neurosciences/Research

Older Age, Lower BMI Predict Success with Upper Airway Stimulation for Sleep Apnea

Findings from ADHERE registry should help guide patient selection

BackPage 2 of 3Next

Advertisement

Ad